During the first quarter of this year, private equity funds managing tens of billions of assets significantly increased their stakes in A-shares. As of April 27, over 20 products from these funds have emerged as top ten shareholders in A-share listed companies, collectively holding market values exceeding 30 billion yuan. Renowned private equity funds have targeted the technology and pharmaceutical sectors as key investment areas, driven by their growth potential and favorable valuations.
